Thermo Fisher launches Invitrogen SuperScript V Reverse Transcriptase for faster, flexible RNA to cDNA conversion
Thermo Fisher Scientific introduces Invitrogen SuperScript V Reverse Transcriptase, an advanced enzyme that offers rapid, flexible, and high-quality RNA to cDNA synthesis with room-temperature stability and streamlined workflows.
6aad50694be739e25594b8ee Invitrogen Superscript V Reverse Transcriptase Pro
Thermo Fisher Scientific has launched Invitrogen SuperScript V Reverse Transcriptase, a next-generation engineered enzyme designed to make converting RNA to cDNA faster, easier, and more flexible.
SuperScript V combines strong performance with room-temperature stability and simpler setup. Available as a standalone enzyme and in ready-to-use master mix formats, it supports workflows ranging from individual experiments to high-throughput and automated cDNA synthesis.
Key features:
Reactions can be prepared at room temperature, with assembled reactions remaining stable for up to 24 hours, giving researchers more flexibility to batch samples, manage delays and support manual, high-throughput and automated workflows.
Speedy cDNA synthesis enables target detection with reaction times as short as one to 10 minutes, helping shorten an important step in RNA analysis.
Supports sensitive, high-quality cDNA synthesis across a broad range of RNA samples, with thermostability up to 65°C.
DTT-free formulations and ready-to-use master mix options help reduce preparation and pipetting steps, while reduced cold-chain requirements provide greater flexibility in reagent handling and shipping.
